Flash Finance

Vijaya Diagnostic Centre LimitedVIJAYACorporate

Healthcare Latest results: Jun 2026 14 quarters of data
Consolidated Standalone
₹1,381.70
MCap ₹14,231 Cr · P/E 73.7
Vijaya Diagnostic Centre Limited — Stock analysis & AI research Vijaya Diagnostic Centre Limited — Multibagger AI analysis Vijaya Diagnostic Centre Limited — Seasonality — best & worst months Vijaya Diagnostic Centre Limited — Technical indicators & charts Vijaya Diagnostic Centre Limited — Technical setup — score, trend, support & resistance Vijaya Diagnostic Centre Limited — Live exchange announcements
📋 High ROCE Stocks📋 High Operating Margin Stocks📋 High Profit Growth Stocks📋 Stocks With Strong Quarterly Results📋 Small Cap Stocks List📋 Quality Stocks 📈 SuperTrend Bearish Signal📈 Unusual Volume Stocks 🏭 Healthcare sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹219 Cr
Sales · Jun 2026
+25.0% YoY
₹95 Cr
Operating Profit · Jun 2026
+36.4% YoY
43.3%
OPM % · Jun 2026
+9.1% YoY
₹53 Cr
Net Profit · Jun 2026
+38.4% YoY
₹5.17
EPS · Jun 2026
+38.2% YoY

📝 Vijaya Diagnostic Centre Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Vijaya Diagnostic Centre Limited reported revenue of ₹219 crore for the quarter ended June 2026 (Q1 FY27), up 25.0% from ₹175 crore in the same quarter last year, and up 5.6% sequentially over the March 2026 quarter.

Net profit rose 38.4% year-on-year to ₹53 crore, from ₹38 crore. Earnings per share (EPS) came in at ₹5.17.

Operating profit stood at ₹95 crore — an operating margin (OPM) of 43.3%, compared with 39.7% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Vijaya Diagnostic Centre Limited posted revenue of ₹764 crore, a growth of 21.9% over FY25, with a net profit of ₹178 crore (up 32.1% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹808 crore with a net profit of ₹193 crore.

Valuation snapshot

At the current price of ₹1,381.70, VIJAYA has a market capitalisation of ₹14,231 crore and a trailing P/E of about 73.7.

Within the Healthcare industry, it is the largest of the 22 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 52.46%, foreign institutional investors (FIIs) 10.66%, domestic institutional investors (DIIs) 32.50%, public shareholders 4.38% of Vijaya Diagnostic Centre Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹14,231 Cr
Current Price ?
₹1,381.7
P/E ?
73.71above ind
Industry P/E ?
34.70
P/B ?
15.09
P/S ?
17.61
P/FCF ?
156.39
Enterprise Value ?
₹14,627 Cr
EV/EBITDA ?
42.05
PEG ?
2.54
Earnings Yield ?
1.8%
Dividend Yield ?
0.14%
Profitability & Returns
Sales (TTM) ?
₹808 Cr
OPM ?
43.1%
Profit after tax (TTM) ?
₹193 Cr
EPS (TTM) ?
₹18.74
ROCE ?
22.0%
ROE ?
20.5%
ROA ?
13.2%
Growth
Sales — latest qtr ?
₹219 Cr
PAT — latest qtr ?
₹53 Cr
YoY qtr sales growth ?
25.0%
YoY qtr profit growth ?
38.4%
Sales growth (3y) ?
19%
Sales growth (5y) ?
16%
Profit growth (3y) ?
29%
Profit growth (5y) ?
17%
Financial Health
Debt ?
₹396 Cr
Debt to Equity ?
0.42
Interest Coverage ?
7.8
Current Ratio ?
N/A
Ownership
Promoter holding ?
52.46%
Change in promoter holding ?
-0.17%
Pledged percentage ?
N/A
Market
Return 3 months ?
3.0%
Return 6 months ?
35.1%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 118119136129141142169156160175189193207219 +25.0% +5.6%
Operating Profit 4847565157567062646979839295 +36.4% +2.9%
Other Income 56753455675679 +21.5% +28.9%
Interest 666666667778910 +50.9% +15.8%
Depreciation 1112141415151517171819212122 +21.8% +6.3%
Profit Before Tax 3635443440385444455257596971 +37.5% +2.8%
Net Profit 2726332531293934333843445353 +38.4% +0.3%
EPS 2.642.553.212.472.982.823.853.263.233.744.154.305.145.17 +38.2% +0.6%
OPM % 40.6% 40.0% 41.4% 39.6% 40.6% 39.1% 41.6% 40.0% 40.1% 39.7% 41.5% 42.8% 44.4% 43.3% +9.1% -2.5%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹627 Cr ₹764 Cr ₹808 Cr +21.9%
Operating Profit ₹253 Cr ₹323 Cr ₹348 Cr +27.7%
OPM % 40.26% 42.21% 43.05% +4.8%
NPM % 21.53% 23.33% 23.89% +8.4%
Other Income ₹19 Cr ₹25 Cr ₹27 Cr +30.2%
Depreciation ₹65 Cr ₹80 Cr ₹84 Cr +23.9%
Interest ₹25 Cr ₹31 Cr ₹35 Cr +24.5%
EBIT ₹188 Cr ₹243 Cr ₹264 Cr +29.0%
PBT ₹181 Cr ₹237 Cr ₹256 Cr +30.5%
Tax ₹46 Cr ₹42 Cr ₹47 Cr -8.5%
Net Profit ₹135 Cr ₹178 Cr ₹193 Cr +32.1%
EPS ₹13.16 ₹17.33 ₹18.76 +31.7%
Material Cost ₹79 Cr ₹66 Cr ₹70 Cr -16.7%
Employee Cost ₹102 Cr ₹90 Cr ₹95 Cr -12.3%
Extraordinary Items ₹1 Cr — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 10101010 +0.0%
Reserves 535643773933 +20.7%
Borrowings 248250292396 +35.6%
Other Liabilities 5759148120 -18.9%
Total Liabilities 8509621,2241,460 +19.3%
Fixed Assets 517582672863 +28.4%
CWIP 2896734 -49.3%
Investments 144254328368 +12.2%
Other Assets 161117157195 +24.2%
Total Assets 8509621,2241,460 +19.3%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 163175207256 +23.7%
Cash from Investing Activity -108-139-165-166 -0.6%
Cash from Financing Activity -41-43-47-63 -34.0%
Net Cash Flow 13-8-627 +550.0%
Free Cash Flow 389213691 -33.1%
CFO/OP 105%98%96%95% -1.0%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 79710 +42.9%
Inventory Days 12261718 +5.9%
Days Payable 172178141143 +1.4%
Cash Conversion Cycle -153-143-116-114 +1.7%
Working Capital Days -37-28-4872 +250.0%
ROCE % 18%19%20%22% +10.0%

👥 Shareholding (latest 5 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Sep 2026 % Chg
Promoters 52.63%52.60%52.60%52.51%52.46% -0.1%
FIIs 19.56%18.27%15.10%13.38%10.66% -20.3%
DIIs 24.07%25.34%28.60%29.93%32.50% +8.6%
Public 3.73%3.77%3.70%4.17%4.38% +5.0%
No. of Shareholders 62,11558,99457,78462,94670,966 +12.7%

⚖️ Peer comparison

Industry: Healthcare · 22 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 VIJAYA Vijaya Diagnostic ₹1,507.80 15,530 82.7 857 187 42.3% 21.8% 19.5% 20.2% 22.8% 37.3%
2 METROPOLIS Metropolis Healthcare ₹596.30 12,370 61.1 1,710 203 24.7% 11.9% 23.6% 31.4% 16.6% 25.7%
3 HCG Healthcare Global ₹704.05 10,512 390.9 2,626 33 18.2% 1.3% 14.6% -53.3% 13.1% 175.3%
4 YATHARTH Yatharth Hospital ₹988.90 9,528 54.1 1,200 171 23.6% 14.3% 36.2% 31.6% 47.6% 16.2%
5 JLHL Jupiter Life ₹277.85 9,109 9.7 1,557 187 22.1% 12.0% 20.9% -6.7% 18.2% -14.5%
6 THYROCARE Thyrocare Technologies ₹555.45 8,841 50.0 876 176 32.1% 20.1% 20.8% 79.4% 24.3% 33.2%
7 KOVAI Kovai Medical ₹6,260.50 6,850 26.7 1,644 256 27.9% 15.6% 15.7% 16.7% 15.3% 20.6%
8 INDRAMEDCO Indraprastha Medical ₹363.20 3,330 17.7 1,524 188 18.0% 12.4% 9.3% 13.7% 11.3% 9.5%
9 KRSNAA Krsnaa Diagnostics ₹543.40 1,763 18.1 816 98 26.8% 12.0% 7.8% 31.0% 22.1% -19.3%
10 SURAKSHA Suraksha Diagnostic ₹311.85 1,624 45.3 325 35 31.4% 10.8% 23.1% 1.4% 20.7% 40.0%
11 SHALBY Shalby ₹132.15 1,418 38.0 1,176 37 12.1% 3.2% 5.0% 1683.0% 11.7% 36.7%
12 GPTHEALTH GPT Healthcare ₹157.90 1,296 27.4 491 48 18.5% 9.8% 15.1% -21.9% 17.8% 62.5%
13 LAXMIDENTL Laxmi Dental ₹196.21 1,080 35.0 287 31 16.2% 10.9% 16.0% -10.1% 13.2% 28.9%
14 NEPHROCARE Nephro Care ₹234.80 387 — — — — — — — 68.4% 347.7%
15 LOTUSEYE Lotus Eye ₹114.50 243 n/m 57 0 8.5% 0.3% 8.4% -89.1% 26.2% 13.0%
16 UNIHEALTH Unihealth Hospitals ₹121.00 190 6.5 132 46 40.9% 34.8% — — 104.6% 71.5%
17 MADHAVBAUG Vaidya Sane ₹148.00 156 19.1 147 8 11.4% 5.6% — — 116.1% 94.3%
18 MHHL Mohini Health ₹57.05 104 — 145 -17 -1.4% -11.7% — — -6.6% -1400.0%
19 MAITREYA Maitreya Medicare ₹120.65 82 — 45 -2 -1.0% -5.5% — — -5.2% -1720.0%
20 AATMAJ Aatmaj Healthcare ₹26.75 60 83.6 24 1 9.7% 2.9% — — 22.5% -39.4%
21 NIDAN Nidan Laborator. ₹33.00 46 30.6 26 2 19.0% 5.9% — — -11.2% -92.0%
22 ARTEMISMED Artemis Medicare ₹315.00 — 48.0 1,081 103 17.4% 9.6% 15.4% 25.9% 16.3% 30.9%
❓ Frequently asked questions
What was Vijaya Diagnostic Centre Limited's revenue in Q1 FY27?
Vijaya Diagnostic Centre Limited reported revenue of ₹219 crore for the quarter ended June 2026 (Q1 FY27), up 25.0% from ₹175 crore in the same quarter last year, and up 5.6% sequentially over the March 2026 quarter.
What was Vijaya Diagnostic Centre Limited's net profit in Q1 FY27?
Net profit rose 38.4% year-on-year to ₹53 crore, from ₹38 crore. Earnings per share (EPS) came in at ₹5.17.
What is VIJAYA's market capitalisation and P/E ratio?
At the current price of ₹1,381.70, VIJAYA has a market capitalisation of ₹14,231 crore and a trailing P/E of about 73.7.
Who owns Vijaya Diagnostic Centre Limited? (shareholding pattern)
As of Sep 2026, promoters held 52.46%, foreign institutional investors (FIIs) 10.66%, domestic institutional investors (DIIs) 32.50%, public shareholders 4.38% of Vijaya Diagnostic Centre Limited.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI